The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis (Q38194507)

30 August 2017

0 references

1 reference

title

The prognostic role of matrix metalloproteinase 2 in gastric cancer: a systematic review with meta-analysis (English)

1 reference

30 August 2017

1 reference

1 reference

Weisong Shen

1

1 reference

30 August 2017

Hongqing Xi

series ordinal

2

1 reference

30 August 2017

Bo Wei

series ordinal

3

1 reference

30 August 2017

Lin Chen

series ordinal

4

1 reference

30 August 2017

language of work or name

1 reference

8 March 2014

1 reference

Journal of Cancer Research and Clinical Oncology

30 August 2017

1 reference

30 August 2017

140

1 reference

30 August 2017

6

1 reference

30 August 2017

1003-1009

1 reference

https://scigraph.springernature.com/pub.10.1007/s00432-014-1630-6

30 August 2017

0 references

cites work

Gelatinase A, membrane type 1 matrix metalloproteinase, and extracellular matrix metalloproteinase inducer mRNA expression: correlation with invasive growth of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Lymphovascular invasion is associated with poor survival in gastric cancer: an application of gene-expression and tissue array techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

p53 and VEGF expression are independent predictors of tumour recurrence and survival following curative resection of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Gelatinase A and membrane-type 1 matrix metalloproteinase mRNA: expressed in adrenocortical cancers but not in adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Matrix metalloproteinases: multifunctional contributors to tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Expression of MMP-2 is associated with progression and lymph node metastasis of gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

MMP-2 but not MMP-9 associated with COX-2 and survival in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Co-evolution of cancer microenvironment reveals distinctive patterns of gastric cancer invasion: laboratory evidence and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Prognostic factors in patients with node-negative gastric cancer: an Indian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Multiparametric in situ mRNA hybridization analysis of gastric biopsies predicts lymph node metastasis in patients with gastric carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

The prognostic value of E-cadherin in gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Prognostic factors for patients after curative resection for proximal gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

Clinicopathological significance of E-cadherin, VEGF, and MMPs in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1630-6

JWA suppresses tumor angiogenesis via Sp1-activated matrix metalloproteinase-2 and its prognostic significance in human gastric cancer

21 January 2018

1 reference

12 December 2020

[MMP-2 expression (type IV collagenase) in gastric cancer]

1 reference

12 December 2020

Clinicopathological significance of MMP-2 and its specific inhibitor TIMP-2 in gastric cancer

1 reference

12 December 2020

The role of matrix metalloproteinases in tumor invasion, metastasis, and angiogenesis.

1 reference

12 December 2020

Prognostic value of p53 protein and MK-1 (a tumor-associated antigen) expression in gastric carcinoma

1 reference

12 December 2020

Differences in prognostic factors between early and advanced gastric cancer

1 reference

12 December 2020

Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma

1 reference

12 December 2020

Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer.

1 reference

12 December 2020

Matrix metalloproteinases and angiogenesis

1 reference

12 December 2020

Claudin-4 expression is associated with tumor invasion, MMP-2 and MMP-9 expression in gastric cancer

1 reference

12 December 2020

Meta-analyses: what they can and cannot do.

1 reference

12 December 2020

Prognostic relevance of MMP-2 (72-kD collagenase IV) in gastric cancer

1 reference

12 December 2020

Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas

1 reference

12 December 2020

10.1007/S00432-014-1630-6

Identifiers

DOI

1 reference

30 August 2017

1 reference